{
    "clinical_study": {
        "@rank": "161591", 
        "arm_group": [
            {
                "arm_group_label": "Experimental toothpaste", 
                "arm_group_type": "Active Comparator", 
                "description": "L-ascorbic acid 2-phosphate magnesium salt / fluoride"
            }, 
            {
                "arm_group_label": "Control toothpaste", 
                "arm_group_type": "Placebo Comparator", 
                "description": "fluoride"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the effect of a dentifrice containing L-ascorbic\n      acid 2-phosphate magnesium salt on gingival inflammation, gingival bleeding and gingival\n      redness."
        }, 
        "brief_title": "Effects of Antioxidant Dentifrice on Gingivitis", 
        "completion_date": {
            "#text": "July 2007", 
            "@type": "Actual"
        }, 
        "condition": "Gingivitis", 
        "condition_browse": {
            "mesh_term": "Gingivitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between \u2265 20 and < 65 y with at least 16 permanent teeth.\n\n          -  Gingival inflammation or mean baseline GI \u2265 0.5 without severe periodontal disease\n             enough to require professional therapy.\n\n          -  Written informed consent to participate.\n\n        Exclusion Criteria:\n\n          -  Taking medications that could influence periodontal tissue health, such as\n             antimicrobials and antihypertensives within 1 month before starting the trial.\n\n          -  Use of orthodontic appliances.\n\n          -  Pregnancy or planning to become pregnant during the trial period.\n\n          -  Previous participation in any other clinical trial.\n\n          -  Inability of patient to understand the study purpose and/or study protocols.\n\n          -  Judged unsuitable by investigators for other reasons."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 23, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02102295", 
            "org_study_id": "LionSDP-6"
        }, 
        "intervention": [
            {
                "arm_group_label": "Experimental toothpaste", 
                "description": "Experimental toothpaste was containing 0.3% L-ascorbic acid 2-phosphate magnesium salt and 950 ppm fluoride. The registered participants were instructed to brush their teeth twice a day in their customary manner.", 
                "intervention_name": "Experimental toothpaste", 
                "intervention_type": "Drug", 
                "other_name": "L-ascorbic acid 2-phosphate magnesium salt toothpaste"
            }, 
            {
                "arm_group_label": "Control toothpaste", 
                "description": "Control toothpaste was containing 950 ppm fluoride. The registered participants were instructed to brush their teeth twice a day in their customary manner.", 
                "intervention_name": "Control toothpaste", 
                "intervention_type": "Drug", 
                "other_name": "Fluoride toothpaste"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antioxidants", 
                "Ascorbic Acid", 
                "Fluorides", 
                "Ascorbate-2-phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Gingivitis", 
            "antioxidant", 
            "dentifrice", 
            "Ascorbic Acid Derivative", 
            "L ascorbic acid 2 phosphate magnesium salt"
        ], 
        "lastchanged_date": "March 29, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Matsudo", 
                        "country": "Japan", 
                        "state": "Chiba", 
                        "zip": "271-8587"
                    }, 
                    "name": "Nihon University Hospital, School of Dentistry at Matsudo"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sendai", 
                        "country": "Japan", 
                        "state": "Miyagi", 
                        "zip": "980-8575"
                    }, 
                    "name": "Tohoku University Dental Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Suita", 
                        "country": "Japan", 
                        "state": "Osaka", 
                        "zip": "565-0871"
                    }, 
                    "name": "Osaka University Dental Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chiyoda-ku", 
                        "country": "Japan", 
                        "state": "Tokyo", 
                        "zip": "101-8310"
                    }, 
                    "name": "Nihon University Dental Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Study of an Ascorbic Acid Derivative Dentifrice in Patients With Gingivitis", 
        "other_outcome": {
            "description": "Salivary antioxidant status was assessed by the ferric reduction ability of plasma (FRAP).", 
            "measure": "salivary antioxidant status", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "overall_official": {
            "affiliation": "Osaka University", 
            "last_name": "Shinya Murakami", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2007", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Gingival Index", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02102295"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Gingivitis Severity Inedex", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Gingival redness was measured as an indicator of the degree of local chromatic changes in the gingiva.", 
                "measure": "Gingival Redness", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Lion Corporation", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Osaka University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Tohoku University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Nihon University", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Lion Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2006", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}